These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
445 related articles for article (PubMed ID: 18442018)
1. 3D-QSAR studies on chromone derivatives as HIV-1 protease inhibitors: application of molecular field analysis. Nunthanavanit P; Anthony NG; Johnston BF; Mackay SP; Ungwitayatorn J Arch Pharm (Weinheim); 2008 Jun; 341(6):357-64. PubMed ID: 18442018 [TBL] [Abstract][Full Text] [Related]
2. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations. Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019 [TBL] [Abstract][Full Text] [Related]
3. 3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes. da Cunha EF; Sippl W; de Castro Ramalho T; Ceva Antunes OA; de Alencastro RB; Albuquerque MG Eur J Med Chem; 2009 Nov; 44(11):4344-52. PubMed ID: 19616874 [TBL] [Abstract][Full Text] [Related]
4. Three-dimensional quantitative structure-activity relationship (3 D-QSAR) and docking studies on (benzothiazole-2-yl) acetonitrile derivatives as c-Jun N-terminal kinase-3 (JNK3) inhibitors. Shaikh AR; Ismael M; Del Carpio CA; Tsuboi H; Koyama M; Endou A; Kubo M; Broclawik E; Miyamoto A Bioorg Med Chem Lett; 2006 Nov; 16(22):5917-25. PubMed ID: 16989998 [TBL] [Abstract][Full Text] [Related]
5. Structure-based QSAR analysis of a set of 4-hydroxy-5,6-dihydropyrones as inhibitors of HIV-1 protease: an application of the receptor-dependent (RD) 4D-QSAR formalism. Santos-Filho OA; Hopfinger AJ J Chem Inf Model; 2006; 46(1):345-54. PubMed ID: 16426069 [TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods. Aparna V; Jeevan J; Ravi M; Desiraju GR; Gopalakrishnan B Bioorg Med Chem Lett; 2006 Feb; 16(4):1014-20. PubMed ID: 16290929 [TBL] [Abstract][Full Text] [Related]
7. Exploring QSARs for inhibitory activity of non-peptide HIV-1 protease inhibitors by GA-PLS and GA-SVM. Deeb O; Goodarzi M Chem Biol Drug Des; 2010 May; 75(5):506-14. PubMed ID: 20486937 [TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR of human immunodeficiency virus (I) protease inhibitors. III. Interpretation of CoMFA results. Opera TI; Waller CL; Marshall GR Drug Des Discov; 1994 Jul; 12(1):29-51. PubMed ID: 7578806 [TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR studies of triazafluorenone inhibitors of metabotropic glutamate receptor subtype 1. Nataraja Sekhar Y; Ravikumar M; Ravi Shashi Nayana M; Mallena SC; Kishore Kumar M Eur J Med Chem; 2008 May; 43(5):1025-34. PubMed ID: 17822809 [TBL] [Abstract][Full Text] [Related]
10. Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis. Debnath AK J Med Chem; 1999 Jan; 42(2):249-59. PubMed ID: 9925730 [TBL] [Abstract][Full Text] [Related]
11. Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents. Chen KX; Xie HY; Li ZG; Gao JR Bioorg Med Chem Lett; 2008 Oct; 18(20):5381-6. PubMed ID: 18835162 [TBL] [Abstract][Full Text] [Related]
12. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments. Pandey G; Saxena AK J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198 [TBL] [Abstract][Full Text] [Related]
13. Cluster analysis and three-dimensional QSAR studies of HIV-1 integrase inhibitors. Yuan H; Parrill A J Mol Graph Model; 2005 Jan; 23(4):317-28. PubMed ID: 15670952 [TBL] [Abstract][Full Text] [Related]
14. Application of CoMFA and CoMSIA 3D-QSAR and docking studies in optimization of mercaptobenzenesulfonamides as HIV-1 integrase inhibitors. Kuo CL; Assefa H; Kamath S; Brzozowski Z; Slawinski J; Saczewski F; Buolamwini JK; Neamati N J Med Chem; 2004 Jan; 47(2):385-99. PubMed ID: 14711310 [TBL] [Abstract][Full Text] [Related]
15. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA. Yi P; Fang X; Qiu M Eur J Med Chem; 2008 May; 43(5):925-38. PubMed ID: 17698256 [TBL] [Abstract][Full Text] [Related]
16. Receptor-independent 4D-QSAR analysis of a set of norstatine derived inhibitors of HIV-1 protease. Senese CL; Hopfinger AJ J Chem Inf Comput Sci; 2003; 43(4):1297-307. PubMed ID: 12870923 [TBL] [Abstract][Full Text] [Related]
17. Exploring the P2 and P3 ligand binding features for hepatitis C virus NS3 protease using some 3D QSAR techniques. Wei HY; Lu CS; Lin TH J Mol Graph Model; 2008 Apr; 26(7):1131-44. PubMed ID: 18024210 [TBL] [Abstract][Full Text] [Related]
18. Optimization and computational evaluation of a series of potential active site inhibitors of the V82F/I84V drug-resistant mutant of HIV-1 protease: an application of the relaxed complex method of structure-based drug design. Perryman AL; Lin JH; Andrew McCammon J Chem Biol Drug Des; 2006 May; 67(5):336-45. PubMed ID: 16784458 [TBL] [Abstract][Full Text] [Related]
19. Pharmacophore identification and validation study of CK2 inhibitors using CoMFA/CoMSIA. Morshed MN; Muddassar M; Pasha FA; Cho SJ Chem Biol Drug Des; 2009 Aug; 74(2):148-58. PubMed ID: 19563463 [TBL] [Abstract][Full Text] [Related]
20. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies. Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]